Rupkatha Banarjee
Staff Scientitst
Rupkatha graduated in 2020 from the University at Buffalo, State University of New York with a Ph.D. in Biology. Her Ph.D. research with Dr. Shermali Gunawardena focused on investigating the regulation of molecular motors by Glycogen synthase kinase 3β and Presenilin during axonal transport. Rupkatha joined the Davis lab in 2020 and is currently working on developing mitochondria-based therapeutics for Alzheimer’s disease.
Courtney “Cori” MacMullen
Scientific Laboratory Manager
Cori graduated from Cedar Crest College in 1999 with a Bachelor’s degree in Genetic Engineering and a minor in Chemistry. She went on to work for 11 years at The Children’s Hospital of Philadelphia where she searched for novel, disease-causing mutations in children with Hyperinsulinism. Cori is currently involved in using neurons derived from hIPSCs to discover compounds to treat mitochondrial dysfunction in brain disorders.
Neelam Shahani
Research Assistant Professor
Neelam graduated from the National Institute of Mental Health and Neurological Science (NIMHANS), Bangalore, India, in 2000 with a Ph.D. in Neuroscience. She obtained her Postdoc training at the University of Heidelberg, Germany. Later, she moved on to Johns Hopkins University as a Senior Researcher, where she focused on integrative signaling in psychiatric and neurodegenerative diseases, and continued this focus in the Subramaniam lab at Scripps, Florida. Neelam joined the Davis lab in 2021 and is currently involved in modeling ALS phenotypes in patient-specific iPSC-derived motor neurons to test compounds to treat mitochondrial dysfunction.
Neelam Sharma
Postdoctoral Associate
Neelam graduated in 2019 from the CSIR-Indian Institute of Chemical Technology, Hyderabad, India with a Ph.D. in Biological Sciences. For her Ph.D., she worked with Dr. Shasi Vardhan Kalivendi, investigating the disease modifying role of the DJ-1 protein in the pathophysiology of Parkinson’s disease. Neelam joined the Davis lab in 2020 as a postdoctoral associate. Her current research focusses on developing mitochondrial based therapeutics for neurodegenerative disorders.
Marianne Monet
Research Assistant I
I obtained my BSc in Molecular Biology and Genetics. I completed my master’s degree in Neuroscience at Istanbul University (Turkey), where I investigated the genetic aspects of epilepsy in human patients. I moved to the U.S. to experience academic freedom and the openness of American scientific society. Prior to joining the Davis Lab, I worked in Dr. Ozdinler’s lab at Northwestern University and contributed to studies investigating therapeutic strategies targeting vulnerable corticospinal motor neurons in neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS).
